Aurinia Pharmaceuticals (AUPH) News Today $11.27 -0.35 (-3.01%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$11.32 +0.05 (+0.49%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AUPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Apogee Therapeutics Reaches 80-Plus Relative Strength Rating BenchmarkOctober 10 at 11:39 AM | msn.comAurinia Pharmaceuticals' (AUPH) "Hold (C)" Rating Reaffirmed at Weiss RatingsOctober 9, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Buys New Stake in Aurinia Pharmaceuticals Inc $AUPHOctober 7, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up - Still a Buy?September 30, 2025 | marketbeat.comAurinia Responds to Now Retracted LinkedIn PostSeptember 29, 2025 | businesswire.comAurinia drops after FDA official criticizes voclosporinSeptember 29, 2025 | msn.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week High - Here's WhySeptember 29, 2025 | marketbeat.comEton Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite RatingSeptember 24, 2025 | msn.comAcropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPHSeptember 23, 2025 | marketbeat.comStrs Ohio Invests $636,000 in Aurinia Pharmaceuticals Inc $AUPHSeptember 21, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 1-Year High - Should You Buy?September 19, 2025 | marketbeat.comTonix Pharmaceuticals Gets Relative Strength Rating UpgradeSeptember 18, 2025 | msn.comOric Pharmaceuticals Stock Scores RS Rating UpgradeSeptember 17, 2025 | msn.comNewAmsterdam Pharma Hits 80-Plus Relative Strength Rating BenchmarkSeptember 17, 2025 | msn.comTarsus Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS RatingSeptember 17, 2025 | msn.comCity Center Advisors LLC Invests $222,000 in Aurinia Pharmaceuticals Inc $AUPHSeptember 16, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month High - Here's What HappenedSeptember 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Grows Holdings in Aurinia Pharmaceuticals Inc $AUPHSeptember 12, 2025 | marketbeat.comVident Advisory LLC Acquires New Stake in Aurinia Pharmaceuticals Inc $AUPHSeptember 12, 2025 | marketbeat.comStocks Showing Market Leadership: Dianthus Therapeutics Earns 91 RS RatingSeptember 9, 2025 | msn.comIeq Capital LLC Invests $266,000 in Aurinia Pharmaceuticals Inc $AUPHSeptember 9, 2025 | marketbeat.comAurinia Pharmaceuticals Inc $AUPH Shares Sold by Invesco Ltd.September 4, 2025 | marketbeat.comTrexquant Investment LP Buys 258,620 Shares of Aurinia Pharmaceuticals Inc $AUPHSeptember 3, 2025 | marketbeat.com50,724 Shares in Aurinia Pharmaceuticals Inc $AUPH Acquired by Jump Financial LLCSeptember 3, 2025 | marketbeat.comAmerican Century Companies Inc. Purchases 58,144 Shares of Aurinia Pharmaceuticals Inc $AUPHSeptember 3, 2025 | marketbeat.comArmistice Capital LLC Sells 1,400,000 Shares of Aurinia Pharmaceuticals Inc $AUPHSeptember 2, 2025 | marketbeat.comRussell Investments Group Ltd. Acquires 72,240 Shares of Aurinia Pharmaceuticals Inc $AUPHSeptember 1, 2025 | marketbeat.comAurinia Pharmaceuticals Inc $AUPH Shares Sold by Charles Schwab Investment Management Inc.August 31, 2025 | marketbeat.comNuveen LLC Invests $10.01 Million in Aurinia Pharmaceuticals Inc $AUPHAugust 25, 2025 | marketbeat.comDeutsche Bank AG Has $2.03 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPHAugust 24, 2025 | marketbeat.com76,328 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by EntryPoint Capital LLCAugust 22, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year High - Here's What HappenedAugust 21, 2025 | marketbeat.comFox Run Management L.L.C. Has $361,000 Holdings in Aurinia Pharmaceuticals Inc $AUPHAugust 21, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Time to Buy?August 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 14, 2025 | marketbeat.comInsider Buying: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Buys 100,000 Shares of StockAugust 6, 2025 | marketbeat.comKevin Tang Acquires 200,000 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) StockAugust 6, 2025 | marketbeat.comAurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Kevin Tang Acquires 1,000,000 SharesAugust 6, 2025 | marketbeat.comAurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade)August 6, 2025 | seekingalpha.comInsider Buying: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Purchases 100,000 Shares of StockAugust 6, 2025 | insidertrades.comAurinia Pharmaceuticals’ Earnings Call: Strong Growth and OptimismAugust 6, 2025 | theglobeandmail.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High After Analyst UpgradeAugust 5, 2025 | marketbeat.comJupiter Asset Management Ltd. Takes $6.05 Million Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 4, 2025 | marketbeat.comXTX Topco Ltd Purchases 63,681 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 4, 2025 | marketbeat.comResearch Analysts Set Expectations for AUPH FY2026 EarningsAugust 4, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for AUPH Q1 Earnings?August 4, 2025 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Just Beat EPS By 9.1%: Here's What Analysts Are Forecasting For This YearAugust 3, 2025 | uk.finance.yahoo.comAurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results, Misses Expectations By $0.01 EPSAugust 3, 2025 | marketbeat.comGSA Capital Partners LLP Increases Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 3, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Trading Up 6.1% Following Analyst UpgradeAugust 2, 2025 | marketbeat.com Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUPH Media Mentions By Week AUPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUPH News Sentiment▼1.020.77▲Average Medical News Sentiment AUPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUPH Articles This Week▼54▲AUPH Articles Average Week Get the Latest News and Ratings for AUPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aurinia Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LEGN News TGTX News PCVX News MTSR News KRYS News PTCT News ARWR News ACLX News KYMR News PTGX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUPH) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurinia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
